Health Care: Drugs

ARIAD Pharmaceuticals Inc (ARIA: NASDAQ)

$6.22 0.06 | 0.97%
08/29/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 6.22
52 Week High 23.00
52 Week Low 2.15
Avg. Daily Vol. (Mil) 8.10
Beta (3 year) 1.33
Share Related Items
Mkt Cap (Mil) 1,163.21
Shares Out (Mil) 187.01
Float (Mil) 167.54
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.90
Current Ratio 5.10
LT Debt/ Equity 2.42
Total Debt / Equity 2.42
Valuation Ratios
Price Earnings n.a.
Price/Sales 23.75
Price/Book 9.48
Price/Cash Flow -4.80
Per Share Data
Earnings -1.33
Sales 0.26
Book Value 0.66
Cash Flow -1.29
Business Summary
Ariad Pharmaceuticals Inc is an oncology company. The Company is focused on discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.
General Information
26 Landsdowne Street
Cambridge, MA 02139-4234
www.ariad.com
Industry : Drugs
Sector: Health Care
Employees: 307
CEO: Dr. Harvey J. Berger,M.D
Short Interest
Current Month (Mil) 50.47
Previous Month (Mil) 51.00
Short Interest Ratio (Days) 5.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -50.20
Return on Investments -58.80
Profitability
Gross Margin 84.50
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with ARIA

Latest ARIA Headlines from TheStreet

More Financial News for ARIA

Press Releases for ARIA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter